Completed business combination with Husky Technologies creating a $7.4 billion best-in-class, diversified compounderRebrands corporate entity to ...
Royalty funding market reached record high of $10 billion in 2025, powered by synthetic royalties Royalty Pharma maintained industry leadership ...
The Change of Control Offers are being conducted in connection with the previously announced Agreement and Plan of Merger, dated October 14, 2025, by and among the Company, Parent and LSF12 Helix ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback